|Bid||31.34 x 800|
|Ask||33.58 x 800|
|Day's Range||32.01 - 33.75|
|52 Week Range||25.92 - 50.26|
|Beta (5Y Monthly)||1.24|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Enrollment ongoing in ATMOSPHERE™, the first of two planned pivotal trials for the subretinal delivery of RGX-314 for the treatment of wet AMD
NEW YORK, NY / ACCESSWIRE / May 5, 2021 / REGENXBIO, Inc. (NASDAQ:RGNX) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 5, 2021 at 4:30 PM Eastern Time.
REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Wednesday, May 5, 2021, at 4:30 p.m. ET to discuss its financial results for the quarter ended March 31, 2021, and recent operational highlights.